Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Odense University Hospital | OTHER |
| Danish Cancer Society | OTHER |
Not provided
Not provided
Not provided
Not provided
This study aims to evaluate the effect of SLN mapping on the incidence and severity of lymphedema in women with early stage cervical and endometrial cancer.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Patients with cervical cancer | All patients receive sentinel node mapping as the conventional treatment. | ||
| Patients with endometrial cancer | All patients receive sentinel node mapping as the conventional treatment. |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Incidence of lymphedema | Incidence of lymphedema will be assessed using patient reported outcome measures. | 3 years |
| Severity of lymphedema | Severity of lymphedema will be assessed using patient reported outcome measures. | 3 years |
| Measure | Description | Time Frame |
|---|---|---|
| Detection rate of sentinel lymph node | Detection of sentinel lymph node per patient, per heme-pelvis and bilaterally | 2 years |
| Mapping of SLN in different types of lymph node stations | Mapping of SLN in areas outside the normal area of pelvic lymphadenectomy |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
See above in eligibility criteria.
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Rigshospitalet | Copenhagen | 2100 | Denmark | |||
| Herlev Hospital |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 33829991 | Derived | Bjornholt SM, Sponholtz SE, Markauskas A, Froding LP, Larsen CR, Fuglsang K, Schledermann D, Mogensen O, Jensen PT. Sentinel lymph node mapping for endometrial and cervical cancer in Denmark. Dan Med J. 2021 Mar 24;68(4):A11200886. |
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D002583 | Uterine Cervical Neoplasms |
| D014594 | Uterine Neoplasms |
| ID | Term |
|---|---|
| D005833 | Genital Neoplasms, Female |
| D014565 | Urogenital Neoplasms |
| D009371 | Neoplasms by Site |
| D009369 | Neoplasms |
Not provided
Not provided
Not provided
Not provided
Not provided
| 2 years |
| Herlev |
| 2730 |
| Denmark |
| Odense University Hospital | Odense | 5000 | Denmark |
| D002577 |
| Uterine Cervical Diseases |
| D014591 | Uterine Diseases |
| D005831 | Genital Diseases, Female |
| D052776 | Female Urogenital Diseases |
| D005261 | Female Urogenital Diseases and Pregnancy Complications |
| D000091642 | Urogenital Diseases |
| D000091662 | Genital Diseases |